261 related articles for article (PubMed ID: 31659311)
1. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs.
Wang Y; Dix MM; Bianco G; Remsberg JR; Lee HY; Kalocsay M; Gygi SP; Forli S; Vite G; Lawrence RM; Parker CG; Cravatt BF
Nat Chem; 2019 Dec; 11(12):1113-1123. PubMed ID: 31659311
[TBL] [Abstract][Full Text] [Related]
2. Mapping the protein interaction landscape for fully functionalized small-molecule probes in human cells.
Kambe T; Correia BE; Niphakis MJ; Cravatt BF
J Am Chem Soc; 2014 Jul; 136(30):10777-82. PubMed ID: 25045785
[TBL] [Abstract][Full Text] [Related]
3. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes.
Chen Y; Craven GB; Kamber RA; Cuesta A; Zhersh S; Moroz YS; Bassik MC; Taunton J
Nat Chem; 2023 Nov; 15(11):1616-1625. PubMed ID: 37460812
[TBL] [Abstract][Full Text] [Related]
4. Expanding chemogenomic space using chemoproteomics.
Jones LH
Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
[TBL] [Abstract][Full Text] [Related]
5. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
6. NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.
Ward CC; Kleinman JI; Nomura DK
ACS Chem Biol; 2017 Jun; 12(6):1478-1483. PubMed ID: 28445029
[TBL] [Abstract][Full Text] [Related]
7. Proteome-wide covalent ligand discovery in native biological systems.
Backus KM; Correia BE; Lum KM; Forli S; Horning BD; González-Páez GE; Chatterjee S; Lanning BR; Teijaro JR; Olson AJ; Wolan DW; Cravatt BF
Nature; 2016 Jun; 534(7608):570-4. PubMed ID: 27309814
[TBL] [Abstract][Full Text] [Related]
8. Ligand and Target Discovery by Fragment-Based Screening in Human Cells.
Parker CG; Galmozzi A; Wang Y; Correia BE; Sasaki K; Joslyn CM; Kim AS; Cavallaro CL; Lawrence RM; Johnson SR; Narvaiza I; Saez E; Cravatt BF
Cell; 2017 Jan; 168(3):527-541.e29. PubMed ID: 28111073
[TBL] [Abstract][Full Text] [Related]
9. [The application of small molecule bioactive probes in the identification of cellular targets].
Zhang J; Zhou HC
Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
[TBL] [Abstract][Full Text] [Related]
10. Small molecule probes of cellular pathways and networks.
Castoreno AB; Eggert US
ACS Chem Biol; 2011 Jan; 6(1):86-94. PubMed ID: 21087032
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Interactome Mapping by Photo-Affinity Labeling (SIM-PAL) to Identify Binding Sites of Small Molecules on a Proteome-Wide Scale.
Flaxman HA; Miyamoto DK; Woo CM
Curr Protoc Chem Biol; 2019 Dec; 11(4):e75. PubMed ID: 31763793
[TBL] [Abstract][Full Text] [Related]
12. Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells.
Offensperger F; Tin G; Duran-Frigola M; Hahn E; Dobner S; Ende CWA; Strohbach JW; Rukavina A; Brennsteiner V; Ogilvie K; Marella N; Kladnik K; Ciuffa R; Majmudar JD; Field SD; Bensimon A; Ferrari L; Ferrada E; Ng A; Zhang Z; Degliesposti G; Boeszoermenyi A; Martens S; Stanton R; Müller AC; Hannich JT; Hepworth D; Superti-Furga G; Kubicek S; Schenone M; Winter GE
Science; 2024 Apr; 384(6694):eadk5864. PubMed ID: 38662832
[TBL] [Abstract][Full Text] [Related]
13. Hotspot Identification on Protein Surfaces Using Probe-Based MD Simulations: Successes and Challenges.
Sayyed-Ahmad A
Curr Top Med Chem; 2018; 18(27):2278-2283. PubMed ID: 30499401
[TBL] [Abstract][Full Text] [Related]
14. A proteome-wide atlas of lysine-reactive chemistry.
Abbasov ME; Kavanagh ME; Ichu TA; Lazear MR; Tao Y; Crowley VM; Am Ende CW; Hacker SM; Ho J; Dix MM; Suciu R; Hayward MM; Kiessling LL; Cravatt BF
Nat Chem; 2021 Nov; 13(11):1081-1092. PubMed ID: 34504315
[TBL] [Abstract][Full Text] [Related]
15. Public resources for chemical probes: the journey so far and the road ahead.
Antolin AA; Workman P; Al-Lazikani B
Future Med Chem; 2021 Apr; 13(8):731-747. PubMed ID: 31778323
[TBL] [Abstract][Full Text] [Related]
16. A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells.
Niphakis MJ; Lum KM; Cognetta AB; Correia BE; Ichu TA; Olucha J; Brown SJ; Kundu S; Piscitelli F; Rosen H; Cravatt BF
Cell; 2015 Jun; 161(7):1668-80. PubMed ID: 26091042
[TBL] [Abstract][Full Text] [Related]
17. Biophysical screening for the discovery of small-molecule ligands.
Ciulli A
Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
[TBL] [Abstract][Full Text] [Related]
18. A chiral trick to map protein ligandability.
Amako Y; Woo CM
Nat Chem; 2019 Dec; 11(12):1080-1082. PubMed ID: 31758156
[No Abstract] [Full Text] [Related]
19. Chemical Proteomics for Expanding the Druggability of Human Disease.
Zhang X
Chembiochem; 2020 Dec; 21(23):3319-3320. PubMed ID: 32964553
[TBL] [Abstract][Full Text] [Related]
20. The Proteome-Wide Potential for Reversible Covalency at Cysteine.
Senkane K; Vinogradova EV; Suciu RM; Crowley VM; Zaro BW; Bradshaw JM; Brameld KA; Cravatt BF
Angew Chem Int Ed Engl; 2019 Aug; 58(33):11385-11389. PubMed ID: 31222866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
